Nishan M. DeSilva
CIK: 0001492386
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RNAC
Cartesian Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About DeSilva Nishan M
DeSilva Nishan M (SEC CIK 0001492386) files insider reports with the SEC as Director of Cartesian Therapeutics, Inc. (RNAC).
Signal8 holds 2 ownership filings by DeSilva Nishan M, all Form 4s, filed between Jan 6, 2025 and Jan 6, 2026. Those filings report 2 transactions, from Jan 2, 2025 to Jan 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on DeSilva Nishan M's filings is in FREDERICK, MD.
Recent filings by DeSilva Nishan M
Other insiders filing for Cartesian Therapeutics, Inc. (RNAC)
- Hoge Elizabeth, 10% Owner
- Kalayoglu Murat, 10% Owner
- Singer Michael, Director
- Brunn Carsten, President and CEO
- Miljkovic Milos, Chief Medical Officer
- Davis Blaine, Chief Financial Officer